多领域认知功能训练对轻度认知障碍和轻度痴呆症的老年人认知功能,工作记忆,注意力和协调的有效性:一年期前性随机对照试验
Chien-Mei Sung1,2, Tso-Ying Lee1,3, Hsin Chu4,5
1School of Nursing, College of Nursing, Taipei Medical University, Taipei, Taiwan.
Journal of global health
|June 30, 2023
概括
多领域认知功能训练改善了老年轻度认知障碍和痴呆症患者的认知功能,工作记忆和选择性注意力. 这些好处持续了一年,这表明有可能延迟认知衰退.
科学领域:
- 老年学是一门学科.
- 认知神经科学 认知神经科学
- 临床心理学 临床心理学
背景情况:
- 在老年人中,工作记忆和注意力等认知功能至关重要.
- 在轻度认知障碍 (MCI) 和痴呆症中进行多领域认知干预的证据有限.
- 本研究研究了多领域认知功能训练 (MCFT) 对这一群体认知结果的影响.
研究的目的:
- 评估MCFT对MCI和轻度痴呆症的老年人认知功能,工作记忆,注意力和协调的有效性.
- 在一年的随访期内评估MCFT的长期影响.
主要方法:
- 一项双盲随机对照试验与72名参与者 (≥65岁) 在台湾北部进行.
- 参与者被分配到MCFT或被动信息活动 (PIA) 中,持续8周 (每周3次).
- 认知功能,工作记忆,注意力 (选择性,视觉空间,分割) 和协调在基线,干预后以及1个月和1年的随访时进行了评估.
主要成果:
- 与PIA相比,MCFT在1个月的随访后显著改善了认知功能,工作记忆和选择性注意力.
- 认知功能,工作记忆,选择性注意力和协调方面的这些改善在1年的随访中得到维持.
- 在视觉空间或分散注意力方面没有观察到显著的改善.
结论:
- 在患有MCI和轻度痴呆症的老年人中,MCFT对全球认知功能,工作记忆,选择性注意力和协调有显著的益处.
- 多领域认知训练可能是一个可行的策略,有助于延迟认知衰退在这个弱势群体.
相关概念视频
01:30Cognitive Development During Adulthood
160
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
160
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
160
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
160
01:22Alzheimer's Disease: Treatment
220
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
220
01:30Dementia
141
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
141